Literature DB >> 35763085

Prevalence of cardiac valvar abnormalities in children and young people with autosomal dominant polycystic kidney disease.

Alexandra Savis1, John M Simpson1, Saleha Kabir1, Kelly Peacock1, Hayley Beardsley1, Manish D Sinha2,3.   

Abstract

BACKGROUND: Valvar abnormalities in children and adults with autosomal dominant polycystic kidney disease (ADPKD) have previously been reported as a frequent occurrence. Mitral valve prolapse (MVP), in particular, has been reported in almost one-third of adult patients and nearly 12% of children with ADPKD. Our objective in this study was to establish the prevalence of valvar abnormalities in a large, contemporary series of children and young people (CYP) with ADPKD.
METHODS: A retrospective, single centre, cross-sectional analysis of the echocardiograms performed on all consecutive children seen in a dedicated paediatric ADPKD clinic. Full anatomical and functional echocardiograms were performed and analysed for valvar abnormalities.
RESULTS: The echocardiograms of 102 CYP with ADPKD (range 0.25-18 years, mean age 10.3 years, SD ± 5.3 years) were analysed. One (0.98%), 3-year-old boy, had MVP. There was no associated mitral regurgitation. Evaluating variations in normal valvar anatomy, 9 (8.8%) patients, aged 7.1 to 18 years, had minor bowing ± visual elongation of either the anterior or posterior leaflet of the mitral valve, none of which fell within the criteria of true MVP. Three (1.9%) patients, 2 boys and 1 girl aged between 7 and 14 years, had trivial or mild aortic regurgitation. No patients had echocardiographic evidence of tricuspid valve prolapse (TVP).
CONCLUSION: In this contemporary cohort of CYP with ADPKD, the incidence of MVP and other valvar lesions is significantly lower than previously reported. A higher resolution version of the Graphical abstract is available as Supplementary information.
© 2022. Crown.

Entities:  

Keywords:  Autosomal dominant kidney disease; Cardiovascular disease; Mitral regurgitation; Mitral valve prolapse; Valvar regurgitation

Year:  2022        PMID: 35763085     DOI: 10.1007/s00467-022-05500-w

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  19 in total

1.  Blood pressure in early autosomal dominant polycystic kidney disease.

Authors:  Robert W Schrier; Kaleab Z Abebe; Ronald D Perrone; Vicente E Torres; William E Braun; Theodore I Steinman; Franz T Winklhofer; Godela Brosnahan; Peter G Czarnecki; Marie C Hogan; Dana C Miskulin; Frederic F Rahbari-Oskoui; Jared J Grantham; Peter C Harris; Michael F Flessner; Kyongtae T Bae; Charity G Moore; Arlene B Chapman
Journal:  N Engl J Med       Date:  2014-11-15       Impact factor: 91.245

Review 2.  Autosomal dominant polycystic kidney disease in children.

Authors:  Melissa A Cadnapaphornchai
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

3.  Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing.

Authors:  Matthew B Lanktree; Amirreza Haghighi; Elsa Guiard; Ioan-Andrei Iliuta; Xuewen Song; Peter C Harris; Andrew D Paterson; York Pei
Journal:  J Am Soc Nephrol       Date:  2018-08-22       Impact factor: 10.121

Review 4.  Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management.

Authors:  Randy L Luciano; Neera K Dahl
Journal:  Nephrol Dial Transplant       Date:  2013-11-08       Impact factor: 5.992

5.  Echocardiographic findings in autosomal dominant polycystic kidney disease.

Authors:  K F Hossack; C L Leddy; A M Johnson; R W Schrier; P A Gabow
Journal:  N Engl J Med       Date:  1988-10-06       Impact factor: 91.245

6.  Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease.

Authors:  D D Ivy; E M Shaffer; A M Johnson; W J Kimberling; A Dobin; P A Gabow
Journal:  J Am Soc Nephrol       Date:  1995-06       Impact factor: 10.121

Review 7.  Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.

Authors:  Tevfik Ecder; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

8.  Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.

Authors:  Binu Porath; Vladimir G Gainullin; Emilie Cornec-Le Gall; Elizabeth K Dillinger; Christina M Heyer; Katharina Hopp; Marie E Edwards; Charles D Madsen; Sarah R Mauritz; Carly J Banks; Saurabh Baheti; Bharathi Reddy; José Ignacio Herrero; Jesús M Bañales; Marie C Hogan; Velibor Tasic; Terry J Watnick; Arlene B Chapman; Cécile Vigneau; Frédéric Lavainne; Marie-Pierre Audrézet; Claude Ferec; Yannick Le Meur; Vicente E Torres; Peter C Harris
Journal:  Am J Hum Genet       Date:  2016-06-02       Impact factor: 11.025

Review 9.  Hypertension in autosomal dominant polycystic kidney disease: a meta-analysis.

Authors:  Matko Marlais; Oliver Cuthell; Dean Langan; Jan Dudley; Manish D Sinha; Paul J D Winyard
Journal:  Arch Dis Child       Date:  2016-06-10       Impact factor: 3.791

10.  The role of parental hypertension in the frequency and age of diagnosis of hypertension in offspring with autosomal-dominant polycystic kidney disease.

Authors:  Robert W Schrier; Ann M Johnson; Kim McFann; Arlene B Chapman
Journal:  Kidney Int       Date:  2003-11       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.